Lindbrook Capital, LLC Meridian Bioscience Inc Transaction History

Lindbrook Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$31.15 - $33.39 $186 - $200	-6 Reduced 50.0%	6 $0
Q3 2022 Nov 10, 2022	BUY	$30.9 - $33.55 $370 - $402	12 New	12 $0
Q2 2022 Aug 01, 2022	BUY	$23.75 - $31.69 $0 - $0	0 New	0 $0
Q1 2022 Apr 21, 2022	SELL	$19.97 - $26.94 $2,476 - $3,340	-124 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$17.35 - $22.5 $555 - $720	-32 Reduced 20.51%	124 $2,000
Q4 2020 Jan 27, 2021	BUY	$15.73 - $21.66 $503 - $693	32 Added 25.81%	156 $3,000
Q1 2020 Apr 22, 2020	BUY	$5.57 - $11.5 $690 - $1,426	124 New	124 $1,000
Q3 2019 Oct 31, 2019	SELL	$9.17 - $12.01 $1,008 - $1,321	-110 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$14.52 - $19.72 $1,597 - $2,169	110 New	110 $1,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.